PVH Corp. (PVH) Stock Forecast
Data as of Aug 1, 2026Consumer Cyclical · Current price $86.89 (-0.22%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 25, 2025 | Jay Sole | UBS | $148.00 | +70.3% |
| Oct 23, 2025 | Ashley Helgans | Jefferies | $98.00 | +12.8% |
| Aug 27, 2025 | Paul Kearney | Barclays | $101.00 | +16.2% |
| Feb 3, 2025 | Ike Boruchow | Wells Fargo | $105.00 | +20.8% |
| Oct 28, 2024 | Robert Drbul | Guggenheim | $105.00 | +20.8% |
| Aug 29, 2024 | Christopher Nardone | Bank of America Securities | $130.00 | +49.6% |
| Aug 28, 2024 | Brooke Roach | Goldman Sachs | $144.00 | +65.7% |
| Aug 28, 2024 | Michael Binetti | Evercore ISI | $125.00 | +43.9% |
| Aug 28, 2024 | Simeon Siegel | BMO Capital | $106.00 | +22.0% |
| Aug 26, 2024 | Dana Telsey | Telsey Advisory | $140.00 | +61.1% |
| Aug 26, 2024 | Ike Boruchow | Wells Fargo | $145.00 | +66.9% |
| Jun 5, 2024 | Matthew Boss | DNB Markets | $157.00 | +80.7% |
| Jun 5, 2024 | Simeon Siegel | Loop Capital Markets | $119.00 | +37.0% |
| Jun 5, 2024 | Brooke Roach | Goldman Sachs | $126.00 | +45.0% |
| Jun 5, 2024 | Jay Sole | UBS | $160.00 | +84.1% |
| Jun 5, 2024 | Michael Binetti | Evercore ISI | $145.00 | +66.9% |
| Jun 3, 2024 | Michael Binetti | Evercore ISI | $140.00 | +61.1% |
| Apr 30, 2024 | Ashley Helgans | Jefferies | $115.00 | +32.4% |
| Apr 15, 2024 | Tom Nikic | Wedbush | $128.00 | +47.3% |
| Apr 4, 2024 | Adrienne Yih | Barclays | $149.00 | +71.5% |
Top Analysts Covering PVH
PVH vs Sector & Market
| Metric | PVH | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.50 | 2.50 | 2.42 |
| Analyst Count | 16 | 12 | 19 |
| Target Upside | +7.5% | +133.5% | +17.1% |
| P/E Ratio | 58.10 | 17.33 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-01 | $2.15B | $2.16B | $2.17B | 7 |
| 2026-11-01 | $2.27B | $2.32B | $2.35B | 3 |
| 2027-01-31 | $9.00B | $9.03B | $9.06B | 9 |
| 2027-02-01 | $2.48B | $2.53B | $2.56B | 3 |
| 2027-05-01 | $2.00B | $2.04B | $2.06B | 6 |
| 2027-08-01 | $2.19B | $2.23B | $2.26B | 5 |
| 2027-11-01 | $2.33B | $2.38B | $2.41B | 4 |
| 2028-01-31 | $9.25B | $9.26B | $9.27B | 9 |
| 2028-02-01 | $2.55B | $2.60B | $2.63B | 3 |
| 2029-01-31 | $9.12B | $9.32B | $9.51B | 1 |
| 2029-02-01 | $9.54B | $9.56B | $9.57B | 4 |
| 2030-01-31 | $9.35B | $9.47B | $9.54B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-08-01 | $2.43 | $2.50 | $2.57 | 7 |
| 2026-11-01 | $3.32 | $3.40 | $3.46 | 2 |
| 2027-01-31 | $11.51 | $11.87 | $12.55 | 6 |
| 2027-02-01 | $4.37 | $4.49 | $4.56 | 2 |
| 2027-05-01 | $2.10 | $2.16 | $2.19 | 5 |
| 2027-08-01 | $2.92 | $3.00 | $3.04 | 4 |
| 2027-11-01 | $3.85 | $3.95 | $4.01 | 3 |
| 2028-01-31 | $13.05 | $13.49 | $13.94 | 2 |
| 2028-02-01 | $4.86 | $4.99 | $5.07 | 4 |
| 2029-01-31 | $14.61 | $14.87 | $15.00 | 1 |
| 2029-02-01 | $16.07 | $16.41 | $16.68 | 1 |
| 2030-01-31 | $16.16 | $16.45 | $16.60 | 1 |
Frequently Asked Questions
What is the analyst consensus for PVH?
The consensus among 16 analysts covering PVH Corp. (PVH) is Buy with an average price target of $93.40.
What is the highest price target for PVH?
The highest price target for PVH is $160.00, set by Jay Sole at UBS on 2024-06-05.
What is the lowest price target for PVH?
The lowest price target for PVH is $60.00, set by Adrienne Yih at Barclays on 2022-09-02.
How many analysts cover PVH?
16 analysts have issued ratings for PVH Corp. in the past 12 months.
Is PVH a buy or sell right now?
Based on 16 analyst ratings, PVH has a consensus rating of Buy (2.50/5) with a +7.5% upside to the consensus target of $93.40.
What are the earnings estimates for PVH?
Analysts estimate PVH will report EPS of $2.50 for the period ending 2026-08-01, with revenue estimated at $2.16B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.